TP53 and colorectal cancer: Whatever the localization of the primary tumor, TP53 is the most mutated among the liquid biopsy-only mutations (between 38% of liquid biopsy-only mutations for colorectal cancers and 71% of liquid biopsy-only mutations for cancers of unknown origin) (Supplementary Fig. S4).